Carmignac Gestion’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-100,556
| Closed | -$399K | – | 123 |
|
|
2025
Q3 | $399K | Hold |
100,556
| – | – | 0.01% | 119 |
|
|
2025
Q2 | $1.21M | Hold |
100,556
| – | – | 0.02% | 104 |
|
|
2025
Q1 | $1.38M | Sell |
100,556
-28,346
| -22% | -$407K | 0.02% | 118 |
|
|
2024
Q4 | $1.84M | Hold |
128,902
| – | – | 0.03% | 102 |
|
|
2024
Q3 | $2.46M | Sell |
128,902
-13,281
| -9% | -$227K | 0.04% | 108 |
|
|
2024
Q2 | $2.77M | Hold |
142,183
| – | – | 0.05% | 97 |
|
|
2024
Q1 | $3.26M | Hold |
142,183
| – | – | 0.05% | 83 |
|
|
2023
Q4 | $2.5M | Hold |
142,183
| – | – | 0.04% | 99 |
|
|
2023
Q3 | $1.86M | Sell |
142,183
-17,840
| -11% | -$270K | 0.03% | 104 |
|
|
2023
Q2 | $2.69M | Hold |
160,023
| – | – | 0.05% | 95 |
|
|
2023
Q1 | $2.5M | Hold |
160,023
| – | – | 0.04% | 87 |
|
|
2022
Q4 | $2.69M | Hold |
160,023
| – | – | 0.05% | 84 |
|
|
2022
Q3 | $2.71M | Buy |
160,023
+667
| +0.4% | +$14.6K | 0.06% | 70 |
|
|
2022
Q2 | $3.51M | Sell |
159,356
-6,354
| -4% | -$154K | 0.07% | 73 |
|
|
2022
Q1 | $5.69M | Hold |
165,710
| – | – | 0.09% | 68 |
|
|
2021
Q4 | $6.84M | Buy |
165,710
+667
| +0.4% | +$43.2K | 0.1% | 80 |
|
|
2021
Q3 | $14.9M | Sell |
165,043
-62,949
| -28% | -$5.56M | 0.19% | 58 |
|
|
2021
Q2 | $16.7M | Sell |
227,992
-8,072
| -3% | -$375K | 0.19% | 56 |
|
|
2021
Q1 | $8.75M | Hold |
236,064
| – | – | 0.1% | 73 |
|
|
2020
Q4 | $9.7M | Buy |
236,064
+73,333
| +45% | +$1.9M | 0.1% | 70 |
|
|
2020
Q3 | $3.76M | Buy |
162,731
+33,557
| +26% | +$867K | 0.04% | 77 |
|
|
2020
Q2 | $3.64M | Sell |
129,174
-2,860
| -2% | -$84.2K | 0.05% | 74 |
|
|
2020
Q1 | $3.37M | Buy |
+132,034
| New | +$4.88M | 0.06% | 70 |
|
Other funds holding CLSD
Carmignac Gestion's CLSD Position: Q4 2025 in Review
Carmignac Gestion sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 100,556 shares — an estimated $399K sold.
Carmignac Gestion first reported a position in CLSD in Q1 2020 and held it in 23 quarters. The position peaked at $16.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- Carmignac Gestion reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- Carmignac Gestion sold 100,556 Clearside Biomedical shares in Q4 2025, an estimated $399K.
- Carmignac Gestion first reported a position in Clearside Biomedical in Q1 2020 and held it in 23 quarters.
- Carmignac Gestion's Clearside Biomedical position peaked at $16.7M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on Carmignac Gestion's 13F filing for Q4 2025, filed 13 Feb 2026.